Trial intelligence / Profile preview

PECARN FLUID: Fluid Therapy and Cerebral Injury in Pediatric DKA

NCT01365793Phase 3Completed

Sponsor
University of California, Davis
Start
Nov 2010
Primary completion
Sep 2016
Countries
1
01

Overview

A Phase 3 trial of sodium chloride, saline in diabetic ketoacidosis (DKA), sponsored by University of California, Davis. Started Nov 2010; status: completed.

02

Drugs

sodium chloridesaline
03

Conditions

diabetic ketoacidosis (DKA)

Beyond the preview

Go deeper on NCT01365793.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01365793.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call